diazepam has been researched along with Phobic Disorders in 58 studies
Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.
diazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5.
Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The response to diazepam and propranolol hydrochloride was compared in 21 patients who (with one exception) met DSM-III criteria for panic disorder and agoraphobia." | 9.05 | Diazepam and propranolol in panic disorder and agoraphobia. ( Anderson, DJ; Clancy, J; Crowe, RR; Ghoneim, MM; Hinrichs, JV; Noyes, R; Slymen, DJ, 1984) |
| "A multi-centre, double-blind trial was carried out in general practice to compare the effectiveness and tolerability of clomipramine and diazepam in patients with agoraphobia or social phobia." | 9.05 | Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice. ( Allsopp, LF; Cooper, GL; Poole, PH, 1984) |
| "The effects of oral doses of diazepam (single dose of 10 mg and a median dose of 30 mg/day for 2 weeks) and propranolol (single dose of 80 mg and a median dose of 240 mg/day for 2 weeks) on psychological performance of patients with panic disorders and agoraphobia were investigated in a double-blind, randomized and crossover design." | 9.05 | Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia. ( Anderson, DJ; Ghoneim, MM; Hinrichs, JV; Noyes, R, 1984) |
| "Fifty-seven chronic agoraphobic outpatients were treated by 12 hours of exposure in vivo on four days over two weeks to check the effects of oral diazepam versus placebo during group exposure, group versus individual exposure, and high versus medium anxiety arousal during individual exposure." | 9.04 | Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation. ( Hafner, J; Marks, I, 1976) |
| "The efficacy of diazepam for controlling phobic avoidance behavior and phobic anxiety and the potential usefulness of the behavioral approach measure for screening new antianxiety drugs was investigated in a double-blind study." | 9.04 | Effects of diazepam on phobic avoidance behavior and phobic anxiety. ( Blackwell, B; Robinson, A; Whitehead, WE, 1978) |
| "The response to diazepam and propranolol hydrochloride was compared in 21 patients who (with one exception) met DSM-III criteria for panic disorder and agoraphobia." | 5.05 | Diazepam and propranolol in panic disorder and agoraphobia. ( Anderson, DJ; Clancy, J; Crowe, RR; Ghoneim, MM; Hinrichs, JV; Noyes, R; Slymen, DJ, 1984) |
| "A multi-centre, double-blind trial was carried out in general practice to compare the effectiveness and tolerability of clomipramine and diazepam in patients with agoraphobia or social phobia." | 5.05 | Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice. ( Allsopp, LF; Cooper, GL; Poole, PH, 1984) |
| "The effects of oral doses of diazepam (single dose of 10 mg and a median dose of 30 mg/day for 2 weeks) and propranolol (single dose of 80 mg and a median dose of 240 mg/day for 2 weeks) on psychological performance of patients with panic disorders and agoraphobia were investigated in a double-blind, randomized and crossover design." | 5.05 | Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia. ( Anderson, DJ; Ghoneim, MM; Hinrichs, JV; Noyes, R, 1984) |
| "Fifty-seven chronic agoraphobic outpatients were treated by 12 hours of exposure in vivo on four days over two weeks to check the effects of oral diazepam versus placebo during group exposure, group versus individual exposure, and high versus medium anxiety arousal during individual exposure." | 5.04 | Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation. ( Hafner, J; Marks, I, 1976) |
| "The efficacy of diazepam for controlling phobic avoidance behavior and phobic anxiety and the potential usefulness of the behavioral approach measure for screening new antianxiety drugs was investigated in a double-blind study." | 5.04 | Effects of diazepam on phobic avoidance behavior and phobic anxiety. ( Blackwell, B; Robinson, A; Whitehead, WE, 1978) |
| "Four patients with panic disorder whose panic attacks responded to benzodiazepine treatment but who suffered persistent anxiety improved after addition of buspirone." | 3.67 | Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder. ( Gastfriend, DR; Rosenbaum, JF, 1989) |
| "Diazepam treatment did not affect the relative rCBF or the subjective or physiological fear indices." | 2.68 | Functional neuroanatomy of visually elicited simple phobic fear: additional data and theoretical analysis. ( Annas, P; Ericson, K; Fredrikson, M; Stone-Elander, S; Wik, G, 1995) |
| "Isocarboxazid was replaced by placebo, using double-blind procedure." | 2.67 | Efficacy of combined antidepressant therapy in resistant neurotic disorder. ( Murphy, S; Tyrer, P, 1990) |
| "Patients were assessed for phobias, obsessions, general psychiatric symptoms and side-effects and each was rated on a special symptom inventory at 0, 2, 4 and 6 weeks of treatment." | 2.64 | A clinical trial of clomipramine and diazepam in the treatment of phobic and obsessional illness. ( Waxman, D, 1977) |
| "Claustrophobia is associated with cardiovascular magnetic resonance (CMR) due to the nature of the technique and lengthy examination times." | 1.31 | Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation. ( Francis, JM; Pennell, DJ, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (75.86) | 18.7374 |
| 1990's | 10 (17.24) | 18.2507 |
| 2000's | 2 (3.45) | 29.6817 |
| 2010's | 2 (3.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orlando, JM | 1 |
| Toth, I | 1 |
| Neumann, ID | 1 |
| Slattery, DA | 1 |
| VANHERCK, J | 1 |
| Leveleki, C | 1 |
| Sziray, N | 1 |
| Levay, G | 1 |
| Barsvári, B | 1 |
| Soproni, K | 1 |
| Mikics, E | 1 |
| Haller, J | 1 |
| Greenblatt, DJ | 1 |
| Shader, RI | 1 |
| Abernethy, DR | 1 |
| Marks, I | 2 |
| Noyes, R | 3 |
| Anderson, DJ | 2 |
| Clancy, J | 1 |
| Crowe, RR | 1 |
| Slymen, DJ | 1 |
| Ghoneim, MM | 2 |
| Hinrichs, JV | 2 |
| Allsopp, LF | 1 |
| Cooper, GL | 1 |
| Poole, PH | 1 |
| Romney, DM | 1 |
| Angus, WR | 1 |
| Bernadt, MW | 1 |
| Silverstone, T | 1 |
| Singleton, W | 1 |
| Cassano, GB | 1 |
| Castrogiovanni, P | 1 |
| Mauri, M | 1 |
| Rutigliano, G | 1 |
| Pirro, R | 1 |
| Cerone, G | 1 |
| Nielsen, NP | 1 |
| Reitano, S | 1 |
| Guidotti, N | 1 |
| Bedarida, D | 1 |
| Marchetti, FP | 1 |
| Catalano, A | 1 |
| Benecchi, MV | 1 |
| Amabile, G | 1 |
| Zanasi, M | 1 |
| Pugliese, L | 1 |
| Rocco, ML | 1 |
| Balestrieri, A | 1 |
| Tansella, M | 1 |
| Burti, L | 1 |
| Pariante, F | 1 |
| Davis, JM | 1 |
| Nasr, S | 1 |
| Spira, N | 1 |
| Vogel, C | 1 |
| Pohl, R | 1 |
| Berchou, R | 1 |
| Rainey, JM | 1 |
| Stern, R | 1 |
| Cohen, SI | 1 |
| File, SE | 2 |
| Zangrossi, H | 2 |
| Viana, M | 1 |
| Graeff, FG | 1 |
| Fredrikson, M | 1 |
| Wik, G | 1 |
| Annas, P | 1 |
| Ericson, K | 1 |
| Stone-Elander, S | 1 |
| Dantendorfer, K | 1 |
| Amering, M | 1 |
| Bankier, A | 1 |
| Helbich, T | 1 |
| Prayer, D | 1 |
| Youssefzadeh, S | 1 |
| Alexandrowicz, R | 1 |
| Imhof, H | 1 |
| Katschnig, H | 1 |
| Pollack, MH | 1 |
| Matthews, J | 1 |
| Scott, EL | 1 |
| Francis, JM | 1 |
| Pennell, DJ | 1 |
| Hafner, J | 1 |
| Hafner, RJ | 1 |
| Dubnitskaia, EB | 1 |
| Basov, AM | 1 |
| Mountjoy, CQ | 1 |
| Roth, M | 1 |
| Garside, RF | 1 |
| Leitch, IM | 1 |
| Whitehead, WE | 1 |
| Blackwell, B | 1 |
| Robinson, A | 1 |
| Waxman, D | 1 |
| Cosgrove, D | 1 |
| Kelly, D | 2 |
| Covelli, V | 1 |
| Munno, I | 1 |
| Decandia, P | 1 |
| Altamura, M | 1 |
| Cannuscio, B | 1 |
| Maffione, AB | 1 |
| Jirillo, E | 1 |
| Sartory, G | 1 |
| MacDonald, R | 1 |
| Gray, JA | 1 |
| Lopez, AL | 1 |
| Kathol, RG | 1 |
| Tyrer, P | 1 |
| Murphy, S | 1 |
| Gastfriend, DR | 1 |
| Rosenbaum, JF | 1 |
| Tearnan, BH | 1 |
| Goetsch, V | 1 |
| Adams, HE | 1 |
| Carlsson, SG | 1 |
| Linde, A | 1 |
| Berggren, U | 1 |
| Harrison, JA | 1 |
| Ananth, J | 1 |
| Lutz, EG | 1 |
| Lutz, MB | 1 |
| Lutz, GE | 1 |
| Finkel, JA | 1 |
| Brady, JP | 1 |
| Lens, F | 1 |
| Yeung, DP | 2 |
| Bott, M | 1 |
| Marks, IM | 1 |
| Viswanathan, R | 1 |
| Lipsedge, MS | 1 |
| Gardner, R | 1 |
| Johnston, D | 1 |
| Gath, D | 1 |
| Silverstone, JT | 1 |
| De Buck, R | 1 |
| McCormick, WO | 2 |
| McEvoy, P | 1 |
| MacKenzie, KR | 1 |
| Cerný, M | 1 |
| Cerná, H | 1 |
| Edmondson, HD | 1 |
| Roscoe, B | 1 |
| Vickers, MD | 1 |
| O'Gorman, EC | 1 |
| Franke, KH | 1 |
| Uldall, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of Pre- and Post-Synaptic Dopamine Function in Developmental Stuttering Using 11C-Raclopride and Positron Emission Tomography[NCT00024960] | 12 participants (Actual) | Observational | 2001-10-03 | Completed | |||
| Maternal-Fetal Monitoring of Patients With Rheumatic Heart Disease During Dental Procedure Under Local Anesthesia[NCT00482573] | Phase 1 | 31 participants (Actual) | Interventional | 2004-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for diazepam and Phobic Disorders
| Article | Year |
|---|---|
Drug therapy. Current status of benzodiazepines.
Topics: Alcoholic Beverages; Alcoholism; Anesthetics; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Bone Di | 1983 |
A brief review of the effects of diazepam on memory.
Topics: Diazepam; Humans; Learning; Memory; Phobic Disorders | 1984 |
Effects of benzodiazepines on the immune system.
Topics: Alprazolam; Antibody Formation; Benzodiazepines; Diazepam; Humans; Immune System; Immunity, Cellular | 1991 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive D | 1986 |
23 trials available for diazepam and Phobic Disorders
| Article | Year |
|---|---|
Comparative studies on benzodiazepines and psychotherapies.
Topics: Agoraphobia; Anxiety; Clinical Trials as Topic; Diazepam; Double-Blind Method; Humans; Palliative Ca | 1983 |
Diazepam and propranolol in panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Depression; Diazepam; Double-Blind | 1984 |
Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice.
Topics: Adolescent; Adult; Aged; Agoraphobia; Clinical Trials as Topic; Clomipramine; Diazepam; Double-Blind | 1984 |
Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Clinical Trials as Topic; Cognition; Diazepam; Double-Blind Method; Fear; Female | 1984 |
Behavioural and subjective effects of beta-adrenergic blockade in phobic subjects.
Topics: Adult; Animals; Diazepam; Fear; Female; Heart Rate; Humans; Male; Mice; Phobic Disorders; Placebos; | 1980 |
A multicenter controlled trial in phobic-obsessive psychoneurosis. The effect of chlorimipramine and of its combinations with haloperidol and diazepam.
Topics: Adult; Aged; Clinical Trials as Topic; Clomipramine; Diazepam; Dose-Response Relationship, Drug; Dou | 1981 |
Anxiety: differential diagnosis and treatment from a biologic perspective.
Topics: Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Diagnosis, Differential; Diazepam; Double- | 1981 |
Functional neuroanatomy of visually elicited simple phobic fear: additional data and theoretical analysis.
Topics: Adult; Arousal; Brain; Brain Mapping; Cerebral Cortex; Diazepam; Double-Blind Method; Fear; Female; | 1995 |
Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation.
Topics: Administration, Oral; Agoraphobia; Anxiety; Behavior Therapy; Chronic Disease; Desensitization, Psyc | 1976 |
[Use of phenazepam in the treatment of neurotic conditions].
Topics: Adult; Affective Symptoms; Anti-Anxiety Agents; Benzodiazepines; Chemical Phenomena; Chemistry; Clin | 1978 |
A clinical trial of phenelzine in anxiety depressive and phobic neuroses.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Agoraphobia; Anxiety Disorders; Clinical Trials as To | 1977 |
Effects of diazepam on phobic avoidance behavior and phobic anxiety.
Topics: Adult; Anxiety; Clinical Trials as Topic; Diazepam; Double-Blind Method; Female; Humans; Implosive T | 1978 |
A clinical trial of clomipramine and diazepam in the treatment of phobic and obsessional illness.
Topics: Adolescent; Adult; Aged; Clomipramine; Diazepam; Dibenzazepines; Female; Humans; Male; Medical Histo | 1977 |
Effects of diazepam on approach, self-reported fear and psychophysiological responses in snake phobics.
Topics: Adolescent; Adult; Animals; Arousal; Combined Modality Therapy; Desensitization, Psychologic; Diazep | 1990 |
Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Benzodiazepines; Depression; Diazepam; Fear; Female; Humans; Hydroco | 1990 |
Efficacy of combined antidepressant therapy in resistant neurotic disorder.
Topics: Adult; Amitriptyline; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Diazepam; Do | 1990 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive D | 1986 |
[A new benzodiazepine screened in a parallel double-blind test].
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Diazepam; Drug Evalua | 1974 |
Enhanced relief of phobias by flooding during waning diazepam effect.
Topics: Adolescent; Adult; Attitude; Behavior Therapy; Chronic Disease; Clinical Trials as Topic; Diazepam; | 1972 |
Arousal levels and attribution effects in diazepam-assisted flooding.
Topics: Adult; Anxiety; Arousal; Behavior Therapy; Clinical Trials as Topic; Diazepam; Female; Galvanic Skin | 1973 |
Lorazepam in phobic disorders: a pilot study.
Topics: Administration, Oral; Anxiety; Benzodiazepinones; Chlorobenzenes; Clinical Trials as Topic; Diazepam | 1973 |
Clinical experience with lorazepam in the treatment of neurotic patients.
Topics: Adult; Anxiety Disorders; Asthenia; Benzodiazepinones; Chlorobenzenes; Clinical Trials as Topic; Dia | 1973 |
[Treatment of phobias with chlordiazepoxide and diazepam].
Topics: Adult; Chlordiazepoxide; Clinical Trials as Topic; Diazepam; Female; Humans; Male; Middle Aged; Phob | 1967 |
32 other studies available for diazepam and Phobic Disorders
| Article | Year |
|---|---|
Animal Behavior Case of the Month.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Behavior, Animal | 2017 |
Social fear conditioning: a novel and specific animal model to study social anxiety disorder.
Topics: Animals; Anti-Anxiety Agents; Conditioning, Psychological; Diazepam; Disease Models, Animal; Dose-Re | 2012 |
[TRIAL CLINICAL EVALUATION OF A NEW TRANQUILIZER OF THE BENZODIAZEPINE GROUP].
Topics: Anxiety; Anxiety Disorders; Benzodiazepines; Chlordiazepoxide; Diazepam; Humans; Hypnotics and Sedat | 1963 |
Pharmacological evaluation of the stress-induced social avoidance model of anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Chlordiazepoxide; Diazepam; Disea | 2006 |
Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.
Topics: Agoraphobia; Antidepressive Agents, Tricyclic; Clomipramine; Diazepam; Double-Blind Method; Humans; | 1982 |
Psychotropic drugs and behaviour therapy.
Topics: Adult; Behavior Therapy; Clomipramine; Diazepam; Female; Humans; Male; Middle Aged; Obsessive-Compul | 1981 |
Alcohol and benzodiazepines generate anxiety, panic and phobias.
Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Female; | 1995 |
"One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?
Topics: Animals; Anti-Anxiety Agents; Anxiety; Appetite Depressants; Carbolines; Cats; Chlordiazepoxide; Dia | 1993 |
Trial 2 in the elevated plus-maze: a different form of fear?
Topics: Animals; Anxiety; Diazepam; Exploratory Behavior; Fear; Handling, Psychological; Male; Models, Psych | 1993 |
A study of the effects of patient anxiety, perceptions and equipment on motion artifacts in magnetic resonance imaging.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Artifacts; Attitude; Diazepam; Equipment Design; Feasibility St | 1997 |
Gabapentin as a potential treatment for anxiety disorders.
Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids | 1998 |
Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation.
Topics: Administration, Oral; Adult; Anti-Anxiety Agents; Diazepam; Female; Heart Diseases; Humans; Incidenc | 2000 |
Fresh symptom emergence after intensive behaviour therapy.
Topics: Agoraphobia; Behavior Therapy; Desensitization, Psychologic; Diazepam; Evaluation Studies as Topic; | 1976 |
Sedation in dentistry.
Topics: Anesthesia, Dental; Anxiety; Communication; Dental Care; Dentist-Patient Relations; Diazepam; Fear; | 1976 |
Physiological measurements in phobic and obsessional disorders.
Topics: Anxiety; Behavior Therapy; Blood Pressure; Cardiac Output; Chlordiazepoxide; Clomipramine; Diazepam; | 1975 |
Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety; Buspirone; Clonazepam; Diazepam; Drug Combinations; | 1989 |
Modification of disease phobia using a multifaceted exposure program.
Topics: Adult; Anxiety; Behavior Therapy; Desensitization, Psychologic; Diazepam; Humans; Hypochondriasis; I | 1985 |
Reduction of dental fear: psychophysiological correlates.
Topics: Adult; Dental Care; Desensitization, Psychologic; Diazepam; Electromyography; Fear; Female; Galvanic | 1986 |
Agoraphobia and paroxysmal cerebral dysrhythmia.
Topics: Agoraphobia; Diazepam; Electroencephalography; Epilepsy; Humans; Phobic Disorders | 1987 |
Diazepam in a patient with chronic schizophrenia complicated by agoraphobia.
Topics: Adult; Agoraphobia; Behavior Therapy; Combined Modality Therapy; Diazepam; Humans; Male; Phobic Diso | 1987 |
Research and training needs in behavior therapy.
Topics: Animals; Autonomic Nervous System; Behavior Therapy; Behavior, Animal; Desensitization, Psychologic; | 1972 |
Diazepam for treatment of phobias.
Topics: Adult; Anxiety; Diazepam; Fear; Female; Humans; Imagination; Male; Methohexital; Middle Aged; Phobic | 1968 |
Diazepam for treatment of phobias.
Topics: Diazepam; Humans; Phobic Disorders | 1968 |
Diazepam for treatment of phobias.
Topics: Diazepam; Humans; Phobic Disorders | 1968 |
Declining-dose drug desensitization for phobias. Clinical and psychophysiological studies.
Topics: Anxiety; Avoidance Learning; Behavior Therapy; Diazepam; Dose-Response Relationship, Drug; Fear; Fem | 1973 |
Nursing care study: phobia in an inadequate personality.
Topics: Adult; Behavior Therapy; Chlorpromazine; Diazepam; Humans; Male; Nitrazepam; Personality Disorders; | 1973 |
The eclectic approach to the treatment of phobias.
Topics: Attitude; Behavior Therapy; Desensitization, Immunologic; Diazepam; Humans; Hypnosis; Male; Middle A | 1973 |
Biochemical evidence of anxiety in dental patients.
Topics: Adolescent; Adult; Anesthesia, Dental; Anesthesia, Local; Anxiety; Catecholamines; Chromatography, P | 1972 |
Treatment of anxiety.
Topics: Adolescent; Adult; Anxiety; Anxiety Disorders; Behavior Therapy; Chlorpromazine; Chronic Disease; Di | 1972 |
Declining-dose drug desensitization for phobias.
Topics: Administration, Oral; Adult; Animals; Anxiety; Avoidance Learning; Behavior Therapy; Behavior, Anima | 1971 |
[On the treatment of phobias with a new anxiolytic drug].
Topics: Adjustment Disorders; Benzazepines; Chlordiazepoxide; Diazepam; Humans; Hypnotics and Sedatives; Neu | 1968 |
[Harmful viewing of television in children].
Topics: Child; Diazepam; Female; Humans; Phobic Disorders; Sleep; Television | 1969 |